A5101440828- Anesthesia and Sedative Agents
- Anesthesia and Neurotoxicity Research
- Airway Management and Intubation Techniques
- Cardiac, Anesthesia and Surgical Outcomes
- Anesthesia and Pain Management
- Obstructive Sleep Apnea Research
- Epilepsy research and treatment
- Nausea and vomiting management
- Foreign Body Medical Cases
- Tracheal and airway disorders
Ajou University
2019-2024
Background Remimazolam is a new ultra short-acting benzodiazepine originally developed as an improved version of midazolam. Recent studies have demonstrated non-inferiority remimazolam to propofol in general anesthesia. However, date, few investigated the induction bolus dose required achieve We aimed determine 95% effective (ED95) loss consciousness (LOC) and appropriate doses for different age groups. Methods Patients aged 20–79 years with American Society Anesthesiologists physical status...
Remimazolam is a new anesthetic drug developed and an ultra-short-acting agent with rapid onset offset. The pharmacology of this seems to be ideal for short surgeries eligible I-gel insertion. Therefore, study aimed determine the optimal bolus dose remimazolam insertion when co-administered remifentanil without neuromuscular blocking agents (NMBAs).Patients aged 19-65 years American Society Anesthesiologists physical status I or II scheduled general anesthesia were enrolled. first was 0.15...
Purpose: Sugammadex rapidly reverses muscle relaxation compared to acetylcholinesterase inhibitors. The long-term outcomes of sugammadex, however, are not well known. We 30-day postoperative following sugammadex and inhibitor use in colorectal surgery patients. Patients methods: Colorectal surgical patients older than 21 were included this retrospective study, dichotomized according reversal agents, (group S), A). assessed outcomes, including total length hospital stay, readmission rate,...
(1) Background: The physiological and pharmacological variations between men women are known to influence drug efficacy. objective of this study was determine the 50% 95% effective doses (ED50 ED95) remimazolam required for i-gel supraglottic airway (ISA) insertion under remifentanil infusion without neuromuscular blocking agents (NMBAs) in both males females. (2) Methods: Patients aged 19–65 years, scheduled general anesthesia using ISA, were enrolled study. divided into two groups based on...
This study aimed to determine the 50% effective dose of remimazolam co-administered with remifentanil for loss consciousness in men and women as well investigate whether there are between-sex differences.
Videolaryngoscopy in nasotracheal intubation has been reported to be better than direct laryngoscopy. The most suitable type of videolaryngoscope remains unknown. This study aimed compare two videolaryngoscopes (McGrath MAC and Pentax AWS) with a Macintosh laryngoscope during intubation.Overall, 123 patients older 18 normal airways who needed were randomly allocated into three groups: (n=41), McGrath (n=41). Intubation time was the primary outcome subdivided steps: nose oropharynx,...